Name: Recombinan Human Anti-PD1 x Human Anti-VEGF Bispecific Antibody (IgG(H)-scFv)
SKU: KN-0825-N29
Rating: 5 (1 reviews)

Recombinant Human Anti-PD1 x Human Anti-VEGF Bispecific Antibody (IgG(H)-scFv) is designed to be expressed as a LC and an extended HC with scFv moiety linked to the C terminus. The anti-PD1 scFvs are fused to the C terminus of the anti-VEGF IgG-Fc chain. It is a symmetric bispecific and tetravalent molecule, bivalent for each antigen specificity, 2+2 antigen-binding valency. This BsAb can block the PD1 signal and inhibit VEGF-mediated proliferation. It is designed for the research of Solid tumors therapy.

Datasheet INQUIRY

Specifications

Targets

PD1 & VEGF

Type

IgG-scFv

Species Reactivity

Human

Application

FuncS; Promising therapeutic agent

Related Disease

Solid tumors

Host Animal 1

Human

Host Animal 2

Human

Targets

Target 1

PD1

Gene ID

5133

UniProt ID

Q15116

Alternative Names

PDCD1; programmed cell death 1; PD1; PD-1; CD279; SLEB2; hPD-1; hPD-l; hSLE1; programmed cell death protein 1; protein PD-1; systemic lupus erythematosus susceptibility 2

Target 2

VEGF

Gene ID

7422

UniProt ID

P15692

Alternative Names

VEGFA; vascular endothelial growth factor A; VPF; VEGF; MVCD1; vascular permeability factor

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Online Inquiry

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinan Human Anti-PD1 x Human Anti-VEGF Bispecific Antibody (IgG(H)-scFv) (KN-0825-N29). Click the button below to contact us or submit your feedback about this product.

Recombinan Human Anti-PD1 x Human Anti-VEGF Bispecific Antibody (IgG(H)-scFv) (CAT#: KN-0825-N29)

Specifications

Targets

Customer Reviews and Q&As